Transcend Capital Advisors LLC Lowers Holdings in Danaher Co. (NYSE:DHR)

Transcend Capital Advisors LLC cut its stake in Danaher Co. (NYSE:DHR) by 2.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,286 shares of the conglomerate’s stock after selling 281 shares during the quarter. Transcend Capital Advisors LLC’s holdings in Danaher were worth $2,229,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in DHR. GPS Wealth Strategies Group LLC acquired a new stake in Danaher in the first quarter worth about $25,000. Freedom Wealth Alliance LLC purchased a new stake in Danaher during the fourth quarter worth $27,000. Chelsea Counsel Co. acquired a new stake in Danaher in the fourth quarter valued at approximately $27,000. Silicon Valley Capital Partners acquired a new position in Danaher in the 1st quarter valued at $29,000. Finally, Stone House Investment Management LLC purchased a new position in Danaher during the first quarter worth approximately $32,000. 76.71% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on DHR shares. Raymond James lifted their price target on shares of Danaher from $270.00 to $290.00 and gave the company an “outperform” rating in a research report on Wednesday, July 26th. Stifel Nicolaus decreased their price objective on Danaher from $250.00 to $240.00 and set a “hold” rating for the company in a report on Wednesday, July 26th. Barclays lifted their price objective on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research report on Tuesday, July 25th. Bank of America boosted their price target on shares of Danaher from $250.00 to $280.00 in a research note on Wednesday, July 26th. Finally, StockNews.com initiated coverage on Danaher in a research report on Tuesday, September 12th. They issued a “hold” rating for the company. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $289.79.

Danaher Trading Up 0.6 %

Shares of NYSE DHR traded up $1.55 during midday trading on Tuesday, reaching $255.32. 990,341 shares of the stock were exchanged, compared to its average volume of 2,861,083. The company has a market capitalization of $188.52 billion, a P/E ratio of 29.83, a P/E/G ratio of 2.75 and a beta of 0.80. Danaher Co. has a 52-week low of $221.22 and a 52-week high of $283.63. The company has a current ratio of 2.08, a quick ratio of 1.70 and a debt-to-equity ratio of 0.35. The stock has a 50 day moving average price of $253.41 and a 200-day moving average price of $245.09.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 25th. The conglomerate reported $2.05 EPS for the quarter, beating the consensus estimate of $2.01 by $0.04. The firm had revenue of $7.16 billion during the quarter, compared to analyst estimates of $7.12 billion. Danaher had a return on equity of 15.03% and a net margin of 20.95%. The business’s quarterly revenue was down 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.76 earnings per share. Equities research analysts expect that Danaher Co. will post 8.84 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Thursday, October 12th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Wednesday, October 11th. This represents a $1.08 dividend on an annualized basis and a yield of 0.42%. Danaher’s dividend payout ratio (DPR) is 12.68%.

Insider Buying and Selling

In related news, SVP Daniel Raskas sold 11,213 shares of the business’s stock in a transaction dated Friday, July 28th. The stock was sold at an average price of $260.65, for a total value of $2,922,668.45. Following the transaction, the senior vice president now owns 38,288 shares in the company, valued at $9,979,767.20. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Danaher news, SVP Jose-Carlos Gutierrez-Ramos sold 590 shares of the stock in a transaction on Monday, August 21st. The stock was sold at an average price of $250.54, for a total value of $147,818.60. Following the sale, the senior vice president now directly owns 6,939 shares of the company’s stock, valued at $1,738,497.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Daniel Raskas sold 11,213 shares of the stock in a transaction on Friday, July 28th. The stock was sold at an average price of $260.65, for a total value of $2,922,668.45. Following the completion of the sale, the senior vice president now directly owns 38,288 shares in the company, valued at $9,979,767.20. The disclosure for this sale can be found here. In the last three months, insiders sold 47,922 shares of company stock valued at $12,552,233. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.